CoChat
Sign Up
Cited by 618Neurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsHereditary Neurological Disorders

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Long-Term Follow-up of von Recklinghausen Neurofibromatosis

Sørensen, Sven Asger, Mulvihill, John J., Nielsen, Arne·1986·New England Journal of Medicine
DOI 10.1056/nejm198604173141603
Open this paper in CoChat — free account

Abstract

To document the natural history of von Recklinghausen neurofibromatosis, we followed up a nationwide cohort of 212 affected patients and families identified in Denmark 42 years ago. We obtained follow-up information on 99 percent. Because all 76 probands were identified through hospitals, they may include a disproportionate number of severe cases of neurofibromatosis. To diminish this effect of selection bias, we distinguished between the probands and their affected relatives. In a comparison with the general population, survival rates were significantly impaired in relatives with neurofibromatosis, worse in probands, and worst in female probands. Malignant neoplasms or benign central nervous system tumors occurred in 45 percent of the probands, giving a relative risk of 4.0 (95 percent confidence limits, 2.8 to 5.6) as compared with expected numbers. Multiple primary neoplasms were found in 15 probands, but only 1 relative. Compared with the general population, male relatives with neurofibromatosis had the same rate of neoplasms, whereas female relatives had a nearly twofold higher rate (relative risk, 1.9; 1.1 to 3.1). Nervous system tumors were disproportionately represented. We conclude that patients with severe neurofibromatosis requiring hospitalization often have a poor prognosis, but incidentally diagnosed relatives may have a considerably better outcome.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198604173141603

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 9

  1. Hope, 1981, Adv Neurol, 29, 33
  2. Borberg, 1951, Acta Psychiatr Neurol, 71, 1
  3. Armitage P. Statistical methods in medical research. Oxford: Blackwell, 1971.
  4. Le Lievre, 1978, J Embryol Exp Morphol, 47, 17
  5. Storm, 1985, Natl Cancer Inst Mongr, 68, 411
  6. Reich, 1976, Am J Dis Child, 130, 888
  7. Manuelidis EE, Solitare GB. Glioblastoma multiforme. In: Minckler J, ed. Pathology of the nervous system. New York: McGraw-Hill, 1971:2049–52.
  8. Boudin, 1970, Presse Med, 78, 1427
  9. Friedman, 1982, JNCI, 69, 1289

Cited by

Sorted by citations

See all 618

Related

See all

Metadata

Authors
Sørensen, S. A., Mulvihill, J. J., & Nielsen, A.
ORCID
Mulvihill, John J.
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
1986-04-17
Volume
314
Issue
16
Pages
1010-1015
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejm198604173141603
OpenAlex
W2330798445
Cited by
617
References
21
Citations by year
2026: 2 · 2025: 5 · 2024: 11 · 2023: 12 · 2022: 13 · 2021: 7 · 2020: 16 · 2019: 16 · 2018: 9 · 2017: 13 · 2016: 17 · 2015: 11 · 2014: 18 · 2013: 18 · 2012: 31
FWCI
17.09
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
  • Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
von Recklinghausen neurofibromatosis, neurofibromatosis type 1, natural history (disease), survival, cancer, central nervous system tumors, multiple primary neoplasms, sex differences, familial neurofibromatosis, prognosis, long-term follow-up
MeSH terms
Brain Neoplasms, Denmark, Female, Follow-Up Studies, Glioma, Humans, Male, Neoplasms, Multiple Primary, Neurofibromatosis 1, Prognosis, Risk, Sex Factors, Skin Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review